HAO

Haoxi Health Technology Limited (HAO) ESG Analysis Analysis (2026)

Invetso Score: 5.8/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.8 (Moderate)

R&D intensity is very low at 0.17% of revenue, suggesting limited peer-leading investment in cleaner processes or product redesign versus more innovation-heavy peers.

The absence of stock-based compensation can reduce governance-linked dilution, but it does not materially strengthen environmental positioning relative to peers.

Debt-to-equity is low at 0.10, which can support flexibility for environmental capex, yet leverage data alone does not indicate a peer advantage in sustainability execution.

Gross margin is only 4.8%, implying limited internal capacity to absorb environmental compliance or transition costs compared with higher-margin peers.

Social

Score:

Zero stock-based compensation may align management incentives more closely with stakeholders, but this is a modest social advantage versus peers rather than a structural differentiator.

Low leverage can reduce workforce and supplier stress during downturns, yet the metric is indirect and does not evidence stronger labor or community outcomes than peers.

Very low R&D spend may limit product or service improvements that typically support customer safety, accessibility, or quality relative to more innovation-oriented peers.

Thin gross margins can constrain investment in employee development and service quality, leaving social positioning broadly in line with or slightly below stronger peers.

Governance

Score:

Zero stock-based compensation is a clear governance positive because it reduces dilution and may lessen pay-related agency concerns versus peers using heavier equity awards.

Low debt-to-equity of 0.10 indicates conservative capital structure, which generally lowers refinancing pressure and supports governance resilience relative to more levered peers.

Net debt to EBITDA of 4.25 is still elevated, so balance-sheet discipline is mixed and weaker than peers with lower leverage and stronger covenant headroom.

Limited R&D intensity can also indicate restrained capital allocation oversight, but the absence of SBC remains the most material governance advantage in the available data.

Overall Score

Score:

HAO’s ESG positioning is broadly moderate versus peers, with governance helped by zero stock-based compensation and low leverage, but limited investment intensity and thin margins temper the profile.

Score Driver: Zero Stock-Based Compensation Is The Clearest Relative ESG Strength In The Available Data.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Haoxi Health Technology Limited. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →